• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏瓣膜钙化与血液透析患者的死亡率相关:一项回顾性队列研究。

Cardiac valve calcification is associated with mortality in hemodialysis patients: a retrospective cohort study.

机构信息

Department of Blood Purification, General Hospital of Northern Theater Command, 83 Wen Hua Road, Shenyang, 110016, Liaoning, China.

Department of Nephrology, Jin Qiu Hospital of Liaoning Province (Geriatric Hospital of Liaoning Province), Shenyang, China.

出版信息

BMC Nephrol. 2022 Jan 22;23(1):43. doi: 10.1186/s12882-022-02670-5.

DOI:10.1186/s12882-022-02670-5
PMID:35065601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8783521/
Abstract

BACKGROUND

Cardiac valve calcification (CVC) is common in end-stage renal disease (ESRD). We investigated the effect of CVC on all-cause and cardiovascular (CV) mortality in maintenance hemodialysis (MHD) patients.

METHODS

A retrospective cohort study was conducted on 434 hemodialysis patients who underwent echocardiography for qualitative assessment of valve calcification with complete follow-up data from January 1, 2014, to April 30, 2021. The baseline data between the CVC and non-CVC groups were compared. The Kaplan-Meier method was used to analyse all-cause and cardiovascular mortality. The association of CVC with all-cause and cardiovascular mortality was evaluated using multivariate Cox regression analysis.

RESULTS

Overall, 27.2% of patients had mitral valve calcification (MVC), and 31.8% had aortic valve calcification (AVC) on echocardiography. Patients with CVC showed significantly higher all-cause (log-rank P < 0.001) and cardiovascular (log-rank P < 0.001) mortality rates than patients without CVC. In multivariate regression analyses, MVC (HR: 1.517, P = 0.010) and AVC (HR: 1.433, P = 0.028) were significant factors associated with all-cause mortality. MVC (HR: 2.340, P < 0.001) and AVC (HR: 2.410, P < 0.001) were also significant factors associated with cardiovascular mortality.

CONCLUSIONS

MVC and AVC increased the risk of all-cause and cardiovascular mortality in MHD patients. Regular follow-up with echocardiography could be a useful method for risk stratification in MHD patients.

摘要

背景

心脏瓣膜钙化(CVC)在终末期肾病(ESRD)中很常见。我们研究了 CVC 对维持性血液透析(MHD)患者全因和心血管(CV)死亡率的影响。

方法

对 434 例接受超声心动图定性评估瓣膜钙化的血液透析患者进行回顾性队列研究,这些患者的完整随访数据来自 2014 年 1 月 1 日至 2021 年 4 月 30 日。比较 CVC 组和非 CVC 组的基线数据。采用 Kaplan-Meier 法分析全因和心血管死亡率。采用多变量 Cox 回归分析 CVC 与全因和心血管死亡率的关系。

结果

总体而言,27.2%的患者在超声心动图上有二尖瓣钙化(MVC),31.8%的患者有主动脉瓣钙化(AVC)。CVC 患者的全因(log-rank P<0.001)和心血管(log-rank P<0.001)死亡率明显高于无 CVC 患者。多变量回归分析显示,MVC(HR:1.517,P=0.010)和 AVC(HR:1.433,P=0.028)是全因死亡的显著相关因素。MVC(HR:2.340,P<0.001)和 AVC(HR:2.410,P<0.001)也是心血管死亡的显著相关因素。

结论

MVC 和 AVC 增加了 MHD 患者全因和心血管死亡的风险。定期进行超声心动图随访可能是 MHD 患者进行风险分层的有用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/8783521/27c7a2b85d10/12882_2022_2670_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/8783521/4c883e71fc3f/12882_2022_2670_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/8783521/27c7a2b85d10/12882_2022_2670_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/8783521/4c883e71fc3f/12882_2022_2670_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/8783521/27c7a2b85d10/12882_2022_2670_Fig2_HTML.jpg

相似文献

1
Cardiac valve calcification is associated with mortality in hemodialysis patients: a retrospective cohort study.心脏瓣膜钙化与血液透析患者的死亡率相关:一项回顾性队列研究。
BMC Nephrol. 2022 Jan 22;23(1):43. doi: 10.1186/s12882-022-02670-5.
2
The influence of cardiac valvular calcification on all-cause and cardiovascular mortality in maintenance hemodialysis patients.维持性血液透析患者心脏瓣膜钙化对全因和心血管死亡率的影响。
Int Urol Nephrol. 2020 May;52(5):943-951. doi: 10.1007/s11255-020-02448-4. Epub 2020 Apr 1.
3
De novo Cardiac Valve Calcification after Hemodialysis in End-Stage Renal Disease Patients Predicts Future Cardiovascular Events: A Longitudinal Cohort Study.终末期肾病血液透析患者发生新的心脏瓣膜钙化可预测未来心血管事件:一项纵向队列研究。
Cardiorenal Med. 2019;9(4):229-239. doi: 10.1159/000494701. Epub 2019 Apr 17.
4
Aortic Artery and Cardiac Valve Calcification are Associated with Mortality in Chinese Hemodialysis Patients: A 3.5 Years Follow-up.主动脉和心脏瓣膜钙化与中国血液透析患者的死亡率相关:一项3.5年的随访研究
Chin Med J (Engl). 2015 Oct 20;128(20):2764-71. doi: 10.4103/0366-6999.167315.
5
Malnutrition as a risk factor for cardiac valve calcification in patients under maintenance dialysis: a cross-sectional study.营养不良作为维持性透析患者心脏瓣膜钙化的风险因素:一项横断面研究。
Int Urol Nephrol. 2020 Nov;52(11):2205-2212. doi: 10.1007/s11255-020-02590-z. Epub 2020 Sep 22.
6
Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis.透析患者心脏瓣膜钙化与心血管或全因死亡风险:一项荟萃分析
BMC Cardiovasc Disord. 2018 Jan 25;18(1):12. doi: 10.1186/s12872-018-0747-y.
7
Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study.在新发生血液透析患者中,心脏瓣膜钙化和 C 反应蛋白与心血管死亡率的关系:一项日本队列研究。
Am J Kidney Dis. 2013 Feb;61(2):254-61. doi: 10.1053/j.ajkd.2012.09.007. Epub 2012 Nov 2.
8
Cardiac valve calcification in patients on maintenance dialysis. The role of malnutrition-inflammation syndrome, adiposity andcomponents of sarcopenia. A cross-sectional study.维持性透析患者的心脏瓣膜钙化。营养不良-炎症综合征、肥胖和肌肉减少症各组成部分的作用。一项横断面研究。
Clin Nutr ESPEN. 2022 Dec;52:421-430. doi: 10.1016/j.clnesp.2022.09.023. Epub 2022 Sep 26.
9
Prognosis and risk factors for cardiac valve calcification in Chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration.中国终末期肾病患者血液透析联合血液透析滤过治疗中心脏瓣膜钙化的预后和危险因素。
Ren Fail. 2022 Dec;44(1):224-232. doi: 10.1080/0886022X.2022.2032742.
10
Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study.心脏瓣膜钙化作为长期腹膜透析患者全因死亡率和心血管死亡率的重要预测指标:一项前瞻性研究。
J Am Soc Nephrol. 2003 Jan;14(1):159-68. doi: 10.1097/01.asn.0000038685.95946.83.

引用本文的文献

1
The role of transient receptor potential channels in chronic kidney disease-mineral and bone disorder.瞬时受体电位通道在慢性肾脏病-矿物质和骨异常中的作用。
Front Pharmacol. 2025 May 9;16:1583487. doi: 10.3389/fphar.2025.1583487. eCollection 2025.
2
Correlation between visceral fat area and cardiac valve calcification in hemodialysis patients.血液透析患者内脏脂肪面积与心脏瓣膜钙化之间的相关性
Front Cardiovasc Med. 2025 Apr 10;12:1574649. doi: 10.3389/fcvm.2025.1574649. eCollection 2025.
3
Development and external validation of a machine learning model for cardiac valve calcification early screening in dialysis patients: a multicenter study.

本文引用的文献

1
The influence of cardiac valvular calcification on all-cause and cardiovascular mortality in maintenance hemodialysis patients.维持性血液透析患者心脏瓣膜钙化对全因和心血管死亡率的影响。
Int Urol Nephrol. 2020 May;52(5):943-951. doi: 10.1007/s11255-020-02448-4. Epub 2020 Apr 1.
2
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 2017慢性肾脏病-矿物质和骨异常(CKD-MBD)诊断、评估、预防及治疗临床实践指南更新
Kidney Int Suppl (2011). 2017 Jul;7(1):1-59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21.
3
用于透析患者心脏瓣膜钙化早期筛查的机器学习模型的开发与外部验证:一项多中心研究
Ren Fail. 2025 Dec;47(1):2491656. doi: 10.1080/0886022X.2025.2491656. Epub 2025 Apr 24.
4
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies.慢性肾脏病中的瓣膜钙化:近期临床和临床前研究的新见解
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i27-i45. doi: 10.1093/ckj/sfae421. eCollection 2025 Mar.
5
The association of peritoneal dialysis and hemodialysis on mitral and aortic valve calcification associated mortality: a meta-analysis.腹膜透析和血液透析对二尖瓣和主动脉瓣钙化相关死亡率的影响:一项荟萃分析。
Sci Rep. 2024 Feb 27;14(1):4748. doi: 10.1038/s41598-024-55326-9.
6
The risk factors and predictive model for cardiac valve calcification in patients on maintenance peritoneal dialysis: a single-center retrospective study.维持性腹膜透析患者心脏瓣膜钙化的危险因素及预测模型:一项单中心回顾性研究。
Ren Fail. 2023;45(2):2271069. doi: 10.1080/0886022X.2023.2271069. Epub 2023 Oct 23.
7
Predictive value of serum β2-microglobulin in cardiac valve calcification in maintenance hemodialysis patients.维持性血液透析患者血清β2-微球蛋白对心脏瓣膜钙化的预测价值
J Thorac Dis. 2023 Sep 28;15(9):4914-4924. doi: 10.21037/jtd-23-1185. Epub 2023 Sep 22.
8
Influencing factors of cardiac valve calcification (CVC) in patients with chronic kidney disease and the impact of CVC on long-term prognosis: a single-center retrospective study.慢性肾脏病患者心脏瓣膜钙化(CVC)的影响因素及 CVC 对长期预后的影响:一项单中心回顾性研究。
PeerJ. 2023 Jun 30;11:e15569. doi: 10.7717/peerj.15569. eCollection 2023.
9
Cardiac Imaging Biomarkers in Chronic Kidney Disease.慢性肾脏病的心脏影像标志物。
Biomolecules. 2023 Apr 29;13(5):773. doi: 10.3390/biom13050773.
10
Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years.心脏瓣膜钙化对中国初发血液透析患者全因死亡率的预测作用:一项为期 4 年的随访研究。
BMC Nephrol. 2023 Feb 16;24(1):37. doi: 10.1186/s12882-023-03076-7.
Prevalence and Prognostic Implications of Mitral and Aortic Valve Calcium in Patients With Chronic Kidney Disease.
慢性肾脏病患者二尖瓣和主动脉瓣钙沉积的流行情况及其预后意义。
Am J Cardiol. 2018 Nov 15;122(10):1732-1737. doi: 10.1016/j.amjcard.2018.08.009. Epub 2018 Aug 21.
4
Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis.透析患者心脏瓣膜钙化与心血管或全因死亡风险:一项荟萃分析
BMC Cardiovasc Disord. 2018 Jan 25;18(1):12. doi: 10.1186/s12872-018-0747-y.
5
Predictive value of echocardiography and its relation to Kt/V and anthropometric parameters in hemodialysis patients.超声心动图在血液透析患者中的预测价值及其与尿素清除指数(Kt/V)和人体测量参数的关系。
Ren Fail. 2015 May;37(4):589-96. doi: 10.3109/0886022X.2015.1007821. Epub 2015 Feb 6.
6
Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial.帕立骨化醇对 CKD 患者左心室质量和功能的影响--OPERA 试验。
J Am Soc Nephrol. 2014 Jan;25(1):175-86. doi: 10.1681/ASN.2013010103. Epub 2013 Sep 19.
7
Left atrial diameter and survival among renal allograft recipients.左心房直径与肾移植受者的生存。
Clin J Am Soc Nephrol. 2013 Dec;8(12):2100-5. doi: 10.2215/CJN.04300413. Epub 2013 Sep 5.
8
The impact of mitral stenosis on left atrial function assessed by two-dimensional speckle tracking echocardiography.二维斑点追踪超声心动图评估二尖瓣狭窄对左心房功能的影响。
Echocardiography. 2013 Aug;30(7):863. doi: 10.1111/echo.12232.
9
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理指南:欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理特别工作组
J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
10
Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study.在新发生血液透析患者中,心脏瓣膜钙化和 C 反应蛋白与心血管死亡率的关系:一项日本队列研究。
Am J Kidney Dis. 2013 Feb;61(2):254-61. doi: 10.1053/j.ajkd.2012.09.007. Epub 2012 Nov 2.